EANO Educational Day - Saturday, October 23, 2021
All times below refer to Central European Summer Time (CEST).
10:10-11:30 hrs
Chairs: Mihaela Lorger, Marco Riva
EDB01.1 CNS taxonomy beyond WHO 2016: Updates on cIMPACT NOW
Dominique Figarella-Branger, France
EDB01.2 Radiomics to aid clinical decision making
Antonella Castellano, Italy
EDB01.3 Artificial intelligence in digital pathology
Jeroen Van der Laak, Netherlands
EDB01.4 Liquid biopsy & Stool microbiome
Andreas Hottinger, Switzerland
Chairs: Annika Malmström, Olivier Chinot
EDC01.1 Surgery for intrinsic spinal cord tumours
Claudius Thomé, Austria
EDC01.2 Unique issues in the management of the elderly neuro-oncology patient
Cressida Lorimer, United Kingdom
EDC01.3 Issues in diagnosis: Can advanced imaging techniques aid early diagnosis of true brain tumour progression after treatment?
Esther Warnert, Netherlands
EDC01.4 Second Look surgery in different tumor types
Manfred Westphal, Germany
10:30-11:30 hrs
Chairs: Helen Bulbeck, Lena Rosenlund
EDN01.1 Matters to patients and their caregivers and why PROMS are just a small part of the picture
Helen Bulbeck, United Kingdom
EDN01.2 Value based healthcare for neuro-oncology patients: why and how?
Monique Baas, Netherlands
11:30-12:00 hrs | BREAK
12:00-13:00 hrs
Chairs: Katrin Lamszus, Rogier Versteeg
EDB02.1 Genetics of Neuroblastoma
Rogier Versteeg, Netherlands
EDB02.2 Epigenetics of Glioma
Sevin Turcan, Germany
EDB02.3 Single cell and spatial transcriptomics
Kiavash Movahedi, Belgium
12:00-13:20 hrs
Chairs: Mihaela Lorger, Riccardo Soffietti
EDC02.1 Surgery first
Marco Riva, Italy
EDC02.2 Radiosurgery first
Fréderic Dhermain, France
EDC02.3 Systemic therapy first
Evangelia D. Razis, Greece
EDC02.4 Brain metastases from CUP
Anna Berghoff, Austria
Chairs: Florien Boele, Karin Piil
EDN02.1 Functional outcome following diagnosis of low-grade glioma
Isabelle Ryden, Sweden
EDN02.2 Language outcome of awake surgery in glioblastoma
Marike Donders-Kamphuis, Netherlands
EDN02.3 Quality of life in long-term survivorship of primary brain tumours
Sé Frances, United Kingdom
EDN02.4 Patient-reported measures - a patient perspective
Lena Rosenlund, Sweden
13:20-13:50 hrs | BREAK
13:50-14:50 hrs
Chairs: Anna Golebiewska, Manuel Valiente
EDB03.1 Single cell analysis of Ependymoma
Mariella Filbin, United States
EDB03.2 Whole genome projects
Jason Huse, United States
EDB03.3 Molecular Profiling of Brain Metastases
Priscilla Brastianos, United States
Chairs: Claudia Panciroli, Martin McCabe
EDC03.1 Epidemiologic spectrum/disease outcomes
Martin McCabe, United Kingdom
EDC03.2 Late CNS radiation & chemotherapy SE (neurocognitive impairments, fertility and endocrinopathies)
Claudia Panciroli, Spain
EDC03.3 Psychosocial and end of life care
Helen Bulbeck, United Kingdom
14:50-15:20 hrs | BREAK
15:20-16:40 hrs
Chairs: Simone Niclou, Pim French
EDB04.1 Exploiting experimental models to identify vulnerabilities of brain metastasis
Manuel Valiente, Spain
EDB04.2 Synaptic communication
Peter Friedl, Netherlands
EDB04.3 Plasticity of Glioblastoma
Anna Golebiewska, Luxembourg
EDB04.4 Sex Differences in Cancer Biology
Joshua Rubin, United States
Chairs: Roberta Rudà, Martin van den Bent
EDC04.1 Glioma
Michael Weller, Switzerland
EDC04.2 Brain metastases
Emilie Le Rhun, France
EDC04.3 EANO updated Guidelines for the management and treatment of Primary CNS Lymphoma
Khè Hoang Xuan, France
EDC04.4 Rare glial and neuronal tumors
Roberta Rudà, Italy
Chairs: Florien Boele, Karin Piil
EDN03.1 Role of the CNS in trial recruitment
Mairi Mackinnon, United Kingdom
EDN03.2 The role of AHPs in Neuro-oncology
Sarah Houghton, United Kingdom
EDN03.3 Presentation to neuro oncology clinical practice and research in Netherlands
Claudine Nogarede, Netherlands
Available all the time
Intro: Florien Boele
EDN04.1 Sleep disturbances and management
Katrine Løppenthin, Denmark
Note that the programme is subject to change and will be continuously updated.